| 000 | 01684 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514011129.0 | ||
| 264 | 0 | _c20020125 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0091-6765 | ||
| 024 | 7 |
_a10.1289/ehp.01109785 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKanno, J | |
| 245 | 0 | 0 |
_aThe OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. _h[electronic resource] |
| 260 |
_bEnvironmental health perspectives _cAug 2001 |
||
| 300 |
_a785-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiological Assay _xstandards |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aClinical Protocols _xstandards |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnvironmental Monitoring _xstandards |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xtoxicity |
| 650 | 0 | 4 |
_aEstrogens _xagonists |
| 650 | 0 | 4 |
_aEthinyl Estradiol _xtoxicity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Planning |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 |
_aOrgan Size _xdrug effects |
| 650 | 0 | 4 | _aProgram Evaluation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aTetrahydronaphthalenes _xtoxicity |
| 650 | 0 | 4 |
_aToxicity Tests _xstandards |
| 650 | 0 | 4 |
_aUterus _xdrug effects |
| 700 | 1 | _aOnyon, L | |
| 700 | 1 | _aHaseman, J | |
| 700 | 1 | _aFenner-Crisp, P | |
| 700 | 1 | _aAshby, J | |
| 700 | 1 | _aOwens, W | |
| 773 | 0 |
_tEnvironmental health perspectives _gvol. 109 _gno. 8 _gp. 785-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1289/ehp.01109785 _zAvailable from publisher's website |
| 999 |
_c11486650 _d11486650 |
||